Clinical Trial Update: Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a lysate-loaded dendritic cell vaccine in newly diagnosed glioblastoma patients; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Lysate-loaded dendritic cell vaccine

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING